Filing Details
- Accession Number:
- 0001209191-15-025166
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-11 16:16:04
- Reporting Period:
- 2015-03-09
- Filing Date:
- 2015-03-11
- Accepted Time:
- 2015-03-11 16:16:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1350360 | Jason Cole | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Svp, Secy. & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-09 | 10,000 | $22.53 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-09 | 4,480 | $110.42 | 5,520 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-03-09 | 1,994 | $111.47 | 3,526 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-03-09 | 1,809 | $112.41 | 1,717 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-03-09 | 1,617 | $113.42 | 100 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-03-09 | 100 | $114.58 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-03-09 | 10,000 | $0.00 | 10,000 | $22.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,000 | 2024-02-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2014
- The range in prices for the transaction reported on this line was $110.02 to $111.00. The average weighted price was $110.4226. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $111.11 to $112.04. The average weighted price was $111.4657. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $112.15 to $112.75. The average weighted price was $112.4139. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $113.20 to $114.11. The average weighted price was $113.4170. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at a rate of twenty-five percent (25%) on March 6, 2015 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
